Share or Print this page
In aggressive pursuit of its vision of a world without Alzheimer’s and all other dementia, the Association once again made its
largest-ever research investment in FY20,
granting more than $47 million to 139 new scientific investigations. Investments included awards to 119 projects funded through the
International Research Grant Program, representing proposals ranked highest by a peer-reviewed process in a highly competitive field of 406 applications submitted from 865 letters of intent. As the world’s leading nonprofit funder of Alzheimer’s and dementia research, the Association is currently investing $208 million in more than 590 active best-of-field projects in 31 countries.
The Association paused funding programs in March 2020 after hearing significant challenges from potential applicants in submitting their necessary documents for consideration as a result of the COVID-19 pandemic. The Association continues to be in touch with multiple institutions and research facility leaders around the globe, and understands that the impact of COVID-19 includes the suspension of research, impact on patient care, rotating schedule of lab staff, halting of wet lab work and more. The Association